IP Library Granted Patent US 8,518,911
Granted Patent B2
US 8,518,911 · App. 13/057,510 · Granted Aug 27, 2013

Pyrazolo[1,5-a]pyridines as MARK inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,518,911
App. No.
13/057,510
Granted
Aug 27, 2013
Kind
B2
Abstract

The invention encompasses pyrazolo[1,5-a]pyridine derivatives which selectively inhibit microtubule affinity regulating kinase (MARK) and are therefore useful for the treatment or prevention of Alzheimer's disease. Pharmaceutical compositions and methods of use are also included.

Claims (291)

1. A compound of formula I:

or a pharmaceutically acceptable salt or hydrate thereof; wherein:

Z is —-N(R 1 )— or —O—;

X 1 is selected from the group consisting of: H, halogen, C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, CF 3 , methoxy, CN, CON(R 3 ) 2 , (trimethylsilyl)ethynyl, phenyl and a monocyclic or bicyclic ring system comprising up to 10 ring atoms, of which 1-3 are selected from N, O and S and the remainder are C, said phenyl and ring system bearing 0-3 substituents independently selected from halogen and C 1-4 alkyl, optionally substituted with up to 3 halogen atoms;

X 2 is selected from the group consisting of: H, halogen, C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, CF 3 , methoxy, CN, CON(R 3 ) 2 , (trimethylsilyl)ethynyl, and phenyl bearing 0 to 5 halogen substituents;

X 3 is selected from the group consisting of: H, OR 3 , N(R 3 ) 2 , C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, CF 3 , methoxy, CN, CON(R 3 ) 2 , (trimethylsilyl)ethynyl, and halogen;

X 4 is selected from the group consisting of: H, halogen, C 3-6 cycloalkyl, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-6 cycloalkenyl, —CN, nitro and N(R 3 ) 2 ; said C 1-6 alkyl optionally substituted with up to 3 halogen atoms and said C 2-6 alkenyl and C 2-6 alkynyl optionally substituted with up to 3 R 5 groups

Y is selected from the group consisting of: N and CH;

R 1 represents H or C 1-4 alkyl which is optionally substituted with OH, CN, CF 3 , C 1-4 alkoxy, amino, C 1-4 alkylamino or di(C 1-4 alkyl)amino;

R 2 is selected from:

(i) H;

(ii) C 1-8 alkyl or C 2-8 alkenyl, either of which optionally bears up to 3 substituents independently selected from halogen, OH, CN, CF 3 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 , NR 3 SO 2 R 4 and phenyl, said phenyl bearing 0 to 5 halogen substituents; and

(iii) C 3-10 cycloalkyl, C 3-10 cycloalkylC 1-4 alkyl, Het, HetC 1-4 alkyl, aryl or arylC 1-4 alkyl, any of which optionally bears up to 4 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 , NR 3 SO 2 R 4 and —P(O)—(OR 3 ) 2 ; where “aryl” refers to phenyl or 5- or 6-membered heteroaryl, either of which phenyl or heteroaryl is optionally fused to a 5- or 6-membered carbocycle or heterocycle, “Het” refers to a nonaromatic or partially aromatic mono- or bicyclic heterocyclic system of up to 10 ring atoms and C 3-10 cycloalkyl and the cyclic portion of C 3-10 cycloalkylC 1-4 alkyl may be fused with phenyl or a 5- or 6-membered heteroaryl;

or R 1 and R 2 together may complete a mono- or bicyclic heterocyclic system of up to 10 ring atoms which optionally bears up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 and NR 3 SO 2 R 4 ;

each R3 independently represents H or C 1-6 alkyl which is optionally substituted with up to 3 halogen atoms or with OH, CN, CF 3 , C 1-4 alkoxy, amino, C 1-4 alkylamino or di(C 1-4 alkyl)amino, or R 3 represents phenyl, benzyl or 5- or 6-membered heteroaryl, any of which optionally bears up to 3 substituents independently selected from halogen, OH, CN, CF 3 , C 1-4 alkyl, C 1-4 alkoxy, amino, C 1-4 alkylamino and di(C 1-4 alkyl)amino;

or two R 3 groups attached to the same atom may complete a heterocycle of up to 6 ring atoms which optionally bears up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , C 1-4 alkoxy, amino, C 1-4 alkylamino and di(C 1-4 alkyl)amino;

R 4 has the same definition as R 3 except that R 4 is not H; and

R 5 is selected from the group consisting of: phenyl, hydroxy, C 3-6 cycloalkyl, and methoxy.

2. A compound according to claim 1 or a pharmaceutically acceptable salt or hydrate thereof, wherein:

Z is —N(R 1 )—;

X 1 is selected from the group consisting of: H, halogen, phenyl, and a monocyclic or bicyclic ring system comprising up to 10 ring atoms, of which 1-3 are selected from N, O and S and the remainder are C, said phenyl and ring system bearing 0-3 substituents independently selected from halogen and C 1-4 alkyl, optionally substituted with up to 3 halogen atoms;

X 2 is selected from the group consisting of: H, halogen and phenyl bearing 0 to 5 halogen substituents;

X 3 is selected from the group consisting of: H, OR 3 , N(R 3 ) 2 , C 1-6 alkyl and halogen;

X 4 is selected from the group consisting of: H, halogen, C 3-6 cycloalkyl and C 1-6 alkyl, optionally substituted with up to 3 halogen atoms;

R 2 is selected from:

(i) H;

(ii) C 1-8 alkyl or C 2-8 alkenyl, either of which optionally bears up to 3 substituents independently selected from halogen, OH, CN, CF 3 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 , NR 3 SO 2 R 4 and phenyl, said phenyl bearing 0 to 5 halogen substituents; and

(iii) C 3-10 cycloalkyl, C 3-10 cycloalkylC 1-4 alkyl, Het, HetC 1-4 alkyl, aryl or arylC 1-4 alkyl, any of which optionally bears up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 and NR 3 SO 2 R 4 ; where “aryl” refers to phenyl or 5- or 6-membered heteroaryl, either of which phenyl or heteroaryl is optionally fused to a 5- or 6-membered carbocycle or heterocycle, and “Het” refers to a nonaromatic mono- or bicyclic heterocyclic system of up to 10 ring atoms;

or R 1 and R 2 together may complete a mono- or bicyclic heterocyclic system of up to 10 ring atoms which optionally bears up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 and NR 3 SO 2 R 4 ;

each R 3 independently represents H or C 1-6 alkyl which is optionally substituted with up to 3 halogen atoms or with OH, CN, CF 3 , C 1-4 alkoxy, amino, C 1-4 alkylamino or di(C 1-4 -alkyl)amino, or R 3 represents phenyl, benzyl or 5- or 6-membered heteroaryl, any of which optionally bears up to 3 substituents independently selected from halogen, OH, CN, CF 3 , C 1-4 alkyl, C 1-4 alkoxy, amino, C 1-4 alkylamino and di(C 1-4 alkyl)amino;

or two R 3 groups attached to the same nitrogen atom may complete a heterocycle of up to 6 ring atoms which optionally bears up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , C 1-4 alkyl, C 1-4 alkoxy, amino, C 1-4 alkylamino and di(C 1-4 alkyl)amino; and

R 4 has the same definition as R 3 except that R 4 is not H.

3. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein Y is CH.

4. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein Y is N.

5. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein X 1 is phenyl bearing 0 to 3 halogen substituents.

6. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein X 1 is H.

7. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein X 1 is halogen.

8. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein X 1 is 1-methyl-1H-pyrazol-4-yl.

9. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein X 3 is H or methoxy.

10. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein X 4 is H, halogen or methyl.

11. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein R 1 is H.

12. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein R 2 is C 3-10 cycloalkyl bearing up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 and NR 3 SO 2 R 4 .

13. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein R 2 is cyclohexyl bearing up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 and NR 3 SO 2 R 4 .

14. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein R 2 is C 1-8 alkyl, which optionally bears up to 3 substituents independently selected from halogen, OH, CN, CF 3 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 , NR 3 SO 2 R 4 and phenyl, said phenyl bearing 0 to 5 halogen substituents.

15. A compound according to claim 2 or a pharmaceutically acceptable salt or hydrate thereof, wherein:

X 1 is selected from the group consisting of H, halogen, phenyl bearing 0 to 3 halogen substituents and 1-methyl-1H-pyrazol-4-yl;

X 3 is H or methoxy;

X 4 is H, halogen or methyl;

R 1 is H; and

R 2 is selected from the group consisting of:

(i) C 1-8 alkyl, which optionally bears up to 3 substituents independently selected from halogen, OH, CN, CF 3 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 , NR 3 SO 2 R 4 and phenyl, said phenyl bearing 0 to 5 halogen substituents; and

(ii) cyclohexyl bearing up to 3 substituents independently selected from halogen, OH, oxo, CN, CF 3 , R 4 , OR 3 , SR 4 , SO 2 R 4 , SO 2 N(R 3 ) 2 , COR 3 , CO 2 R 3 , CON(R 3 ) 2 , N(R 3 ) 2 , NR 3 COR 4 and NR 3 SO 2 R 4 .

16. A compound selected from the group consisting of:

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-[6-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-chloro-pyrazolo{1,5-a]pyridine-3-yl-1,3-thiazole-2-carboxamide;

N-(2-amino-3,3,3-trifluoro-1-phenylpropyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,2R)-2-amino-1,2-diphenylethyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-N-(2,2,2-trifluoroethyl)-1,3-thiazole-2-carboxamide;

N-[2-amino-1-phenylethyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-bromo-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-fluoropyrazolo{1,5-a]pyridine-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-fluoropyrazolo{1,5-a]pyridine-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-methyl-pyrazolo{1,5-a]pyridine-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-4-(4-fluoropyrazolo[1,5-a]pyridin-3-yl)-5-methyl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-4-(6-chloropyrazolo[1,5-a]pyridin-3-yl)-5-methyl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-4-(6-bromopyrazolo[1,5-a]pyridin-3-yl)-5-methyl-1,3-thiazole-2-carboxamide;

N-[(1R,2R)-2-amino-1,2-diphenylethyl]-5-methyl-4-pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(cis)-2-aminocyclohexyl]-5-methyl-4-pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(cis)-2-aminocyclohexyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-(2-amino-1-phenylethyl)-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S,2S)-2-amino-1,2-diphenyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-2-hydroxy-1-phenylethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(2-chlorophenyl)-2-hydroxyethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(3-chloro-5-fluorophenyl)-2-hydroxyethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(4-chlorophenyl)-2-hydroxyethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(3-fluorophenyl)-2-hydroxyethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(4-chlorophenyl)-2-hydroxyethyl]-5-methyl-4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(cis)-2-aminocyclohexyl]-4-(4-methoxy-6-[phenylpyrazolo{1,5-a]pyridine-3-yl)-2-thiophenecarboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-4-methoxy-6-phenylpyrazolo[1,5-a]pyridin-3-yl]-2-thiophenecarboxamide;

4-(4-methoxy-6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-2-thiophenecarboxamide;

N-[(1S)-2-hydroxy-1-phenylethyl]-4-methoxy-6-phenylpyrazolo[1,5-a]pyridin-3-yl]-2-thiophenecarboxamide;

N-[(1S)-2-hydroxy-1-phenylethyl]-4-methoxy-6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-2-thiophenecarboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-4-[6-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-5-methyl-2-thiophenecarboxamide;

N-(3-amino-4,4,4-trifluorobutyl)-4-(4-methoxy-6-phenylpyrazolo[1,5-a]pyridin-3-yl]-2-thiophenecarboxamide;

N-[(cis)-2-aminocyclohexyl]-4-pyrazolo[1,5-a]pyridin-3-yl]-2-thiophenecarboxamide; and

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-2-thiophenecarboxamide;

or a pharmaceutically acceptable salt of any of the foregoing compounds.

17. A compound selected from the group consisting of:

{4-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]piperazin-2-yl}methanol;

3-(5-Chloro-2-{[2-(difluoromethyl)piperazin-1-yl]carbonyl}-1,3-thiazol-4-yl)pyrazolo[1,5-a]pyridine;

{4-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]morpholin-3-yl}methanol;

5-Chloro-N-(4-hydroxy-1,1-dioxidotetrahydro-3-thienyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-(5-Chloro-2-{[2-(trifluoromethyl)piperazin-1-yl]carbonyl}-1,3-thiazol-4-yl)pyrazolo[1,5-a]pyridine;

(3R,4R)-1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-3-fluoropiperidin-4-amine;

(3S,4R)-1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-3-fluoropiperidin-4-amine;

N-[(3R,4R)-4-amino-1-benzylpyrrolidin-3-yl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

2-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-2,3-dihydro-1H-spiro[isoquinoline-4,4′-piperidine];

5-Chloro-N-[(4-phenylpiperidin-4-yl)methyl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2,3-dihydrospiro[indene-1,4′-piperidin]-3-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-[(3S)-1-methylpyrrolidin-3-yl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-(1,2,3,4-tetrahydroisoquinolin-1-ylmethyl)-1,3-thiazole-2-carboxamide;

{3-Amino-1-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]pyrrolidin-3-yl}methanol;

5-Chloro-N-piperidin-3-yl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]pyrrolidin-3-amine;

3-[5-Chloro-2-(piperazin-1-ylcarbonyl)-1,3-thiazol-4-yl]pyrazolo[1,5-a]pyridine;

N-(2-Aminoethyl)-5-chloro-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Aminoethyl)-5-chloro-N-ethyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-N-methylpyrrolidin-3-amine;

3-{5-Chloro-2-[(2-methylpiperazin-1-yl)carbonyl]-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

N-[(1-Aminocyclopentyl)methyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1-Aminocyclohexyl)methyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-1,2,3,4-tetrahydroquinolin-3-amine;

N-(2-Amino-2-phenylethyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Aminoethyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-pyrrolidin-3-yl-1,3-thiazole-2-carboxamide;

3-{5-Chloro-2-[(3-methylpiperazin-1-yl)carbonyl]-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

N-(3-Aminocyclohexyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-{5-Chloro-2-[(3-methylpiperazin-1-yl)carbonyl]-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

N-(3-Aminocyclohexyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

1-{1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-4-phenylpiperidin-4-yl}methanamine;

N-(4-Amino-1,1-dioxidotetrahydro-3-thienyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Amino-2-methylpropyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-oxopiperidin-3-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1S,2R)-2-aminocyclopentyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1-aminocycloheptyl)methyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(1-methyl-2-oxopyrrolidin-3-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(3,3-difluorocyclopentyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Azetidin-1-yl-3,3,3-trifluoropropyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-[5-Chloro-2-(morpholin-4-ylcarbonyl)-1,3-thiazol-4-yl]pyrazolo[1,5-a]pyridine;

3-{5-Chloro-2-[(2,6-dimethylmorpholin-4-yl)carbonyl]-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

3-{5-Chloro-2-[(4-methylpiperazin-1-yl)carbonyl]-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

5-Chloro-N-(2-morpholin-4-ylethyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]piperidin-4-ol;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-yl)carbonyl]-N,N-dimethylpiperidin-4-amine;

5-Chloro-N-[1-(hydroxymethyl)-2-methylpropyl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

Diethyl {1-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-yl)carbonyl]piperidin-4-yl}phosphonate;

5-Chloro-N-(2-hydroxycyclopentyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2,3-dihydroxypropyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-hydroxy-2-methylpropyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-N,N-dimethylpiperidin-3-amine;

5-Chloro-N-(2-oxopyrrolidin-3-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-[(3R)-1-isopropylpyrrolidin-3-yl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-[(3S)-1-isopropylpyrrolidin-3-yl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-[2-(dimethylamino)-3,3,3-trifluoropropyl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-[3,3,3-trifluoro-2-(3-fluoroazetidin-1-yl)propyl]-1,3-thiazole-2-carboxamide;

5-Chloro-N-(4-hydroxy-1,1-dioxidotetrahydro-3-thienyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

(2S)-2-Anilino-2-phenylethyl 5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxylate;

(2S)-2-Anilinopropyl 5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxylate;

5-Chloro-N-[(1S)-2-hydroxy-1-methylethyl]-N-phenyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-phenyl-4-pyrazolo[1,5-a]pyridin-3-yl-N-(2,2,2-trifluoroethyl)-1,3-thiazole-2-carboxamide;

5-Chloro-N-isopropyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-ethyl-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-hydroxyethyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-ethyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-methoxyethyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-[5-Chloro-2-(piperidin-1-ylcarbonyl)-1,3-thiazol-4-yl]pyrazolo[1,5-a]pyridine;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-cyclohexyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-Benzyl-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-(pyridin-3-ylmethyl)-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-(2-thienylmethyl)-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-(2-pyrrolidin-1-ylethyl)-1,3-thiazole-2-carboxamide;

5-Chloro-1-(2,6-dimethylphenyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-{2-[(4-Acetylpiperazin-1-yl)carbonyl]-5-chloro-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

5-Chloro-N-(3-phenylpropyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(3-chlorobenzyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-quinolin-7-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-[4-(trifluoromethyl)benzyl]-1,3-thiazole-2-carboxamide;

3-{2-[(4-Benzylpiperidin-1-yl)carbonyl]-5-chloro-1,3-thiazol-4-yl}pyrazolo[1,5-a]pyridine;

3-(5-Chloro-2-{[4-(3-methoxyphenyl)piperazin-1-yl]carbonyl}-1,3-thiazol-4-yl)pyrazolo[1,5-a]pyridine;

5-Chloro-N-ethyl-N-phenyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-isopropyl-N-phenyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Anilinocyclohexyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-methyl-N-(3-methylphenyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-(5-Chloro-2-{[3-(methylsulfonyl)pyrrolidin-1-yl]carbonyl}-1,3-thiazol-4-yl)pyrazolo[1,5-a]pyridine;

N-[(1R)-1-(Aminomethyl)-2,2,2-trifluoroethyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Aminoethoxy)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(Aminomethyl)-2,2,2-trifluoroethyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-hydroxyethoxy)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Anilinocyclohexyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2,4-difluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2,5-difluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2,3-difluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(4-chlorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(3-Aminophenyl)-5-chloro-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-methyl-N-(4-methylphenyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-N-pyridin-2-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2,6-difluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-methyl-N-(3-methylphenyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-N-(2,2,2-trifluoroethyl)-1,3-thiazole-2-carboxamide;

5-Chloro-N-(3-hydroxyphenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-2-Aminocyclohexyl]-5-chloro-4-[(6-trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-chlorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-methyl-N-(2-methylphenyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(4-fluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(3-chlorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(3-fluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1S,6S)-2-Aminocyclohexyl]-5-chloro-4-[(6-trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-chlorophenyl)-N-methyl-4-pyrazolo pyridin-3-yl-1,3-thiazole-2-carboxamide;

{4-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]morpholin-2-yl}methanol;

1-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-2-yl)carbonyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine;

5-Chloro-N-(3-fluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[1-(Aminomethyl)-6-fluoro-2,3-dihydro-1H-inden-1-yl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-methyl-N-phenyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

3-[2-(Piperidin-1-ylcarbonyl)-1,3-thiazol-4-yl]pyrazolo[1,5-a]pyridine;

N-[1-(Aminomethyl)-5-fluoro-2,3-dihydro-1H-inden-1-yl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[1-(Aminomethyl)-4-fluoro-2,3-dihydro-1H-inden-1-yl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[1-(Aminomethyl)-2,3-dihydro-1H-inden-1-yl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Amino-3,3,3-trifluoro-1-phenylpropyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-(2-Amino-3,3,3-trifluoro-1-phenylpropyl)-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1S)-1-(Aminomethyl)-2,2,2-trifluoro-1-methylethyl]-5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

5-Chloro-N-(2-fluorophenyl)-N-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,2S)-2-amino-6,6-difluoro-2-methylcyclohexyl]-5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

5-Chloro-N-[(1R,6S)-2,2-difluoro-6-hydroxycyclohexyl]-4-(pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(6-iodopyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-bromopyrazolo[1,5-a]pyridin-3-yl)-5-chloro-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-[5-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-[(6-trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(6-methoxypyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(6-ethylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

3-[2-({[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]amino}carbonyl)-5-chloro-1,3-thiazol-4-yl]pyrazolo[1,5-a]pyridine-5-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-(6-fluoropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-chloro-4-(5-chloropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(5-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(5-chloro-6-fluoropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-ethylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(5-chloro-6-fluoropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-methoxypyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-iodopyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-isopropenylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(5-chloropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-cyanopyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-[6-methoxy-5-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-{6-[(trimethyl Silyl)ethynyl]pyrazolo[1,5-a]pyridin-3-yl}-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(4,6-difluoropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(4-chloro-6-methoxypyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-ethylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(5-chloro-6-fluoropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-methoxypyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-chloro-4-(6-cyclopropylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-ethyl-4-(6-fluoropyrazolo[1,5-a]pyridin-3-yl)thiophene-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-isopropyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-isopropyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-ethyl-4-[6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]thiophene-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-ethyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-methyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-fluoropyrazolo[1,5-a]pyridin-3-yl)-5-methyl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(4,6-difluoropyrazolo[1,5-a]pyridin-3-yl)-5-methylthiophene-2-carboxamide;

N-[(trans)-4-Amino-1,1-dioxidotetrahydro-2H-thiopyran-3-yl]-5-methyl-4-(pyrazolo[1,5-a]pyridin-3-yl) thiophene-2-carboxamide;

N-[(cis)-4-Amino-1,1-dioxidotetrahydro-2H-thiopyran-3-yl]-5-methyl-4-(pyrazolo[1,5-a]pyridin-3-yl) thiophene-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-ethyl-4-[6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]thiophene-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-ethyl-4-(6-fluoropyrazolo[1,5-a]pyridin-3-yl)thiophene-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(4,6-difluoropyrazolo[1,5-a]pyridin-3-yl)-5-methylthiophene-2-carboxamide;

N-[(trans)-4-amino-1,1-dioxidotetrahydro-2H-thiopyran-3-yl]-5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl) thiophene-2-carboxamide;

N-[(cis)-4-amino-1,1-dioxidotetrahydro-2H-thiopyran-3-yl]-5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl) thiophene-2-carboxamide;

N-[(trans)-3-amino-1,1-dioxidotetrahydro-2H-thiopyran-4-yl]-5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl) thiophene-2-carboxamide;

N-[(cis)-3-amino-1,1-dioxidotetrahydro-2H-thiopyran-4-yl]-5-chloro-4-(pyrazolo[1,5-a]pyridin-3-yl) thiophene-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-(phenylethynyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-(3-hydroxy-3-methylbut-1-yn-1-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-ethynyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-(cyclopropylethynyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-(3-methoxyprop-1-yn-1-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-cyclopent-1-en-1-yl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-isopropenyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-isopropenyl-4-[6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-pyrazolo[1,5-a]pyridin-3-yl-5-vinyl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-4-(6-fluoropyrazolo[1,5-a]pyridin-3-yl)-5-isopropenyl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-[(1E)-but-1-en-1-yl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-4-pyrazolo[1,5-a]pyridin-3-yl-5-vinyl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-(2-methylprop-1-en-1-yl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-[(E)-2-cyclohexylvinyl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-[(E)-2-cyclopropylvinyl]-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-cyclopropyl-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-cyano-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-amino-2,2-difluorocyclohexyl]-5-(difluoromethyl)-4-pyrazolo[1,5-a]pyridin-3-ylthiophene-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-(difluoromethyl)-4-(6-fluoropyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-2-carboxamide;

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-(difluoromethyl)-4-[6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]-1,3-thiazole-2-carboxamide;

N-[(1R,6R)-6-Amino-2,2-difluorocyclohexyl]-5-nitro-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

2-(Piperidin-1-ylcarbonyl)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazol-5-amine; and

N-[(1R,6S)-6-Amino-2,2-difluorocyclohexyl]-5-(dimethylamino)-4-pyrazolo[1,5-a]pyridin-3-yl-1,3-thiazole-2-carboxamide;

or a pharmaceutically acceptable salt of any of the foregoing compounds.

18. A compound according to claim 1 according to Formula Ia

or a pharmaceutically acceptable salt or hydrate thereof.

19. A pharmaceutical composition comprising a compound of formula I as defined in claim 1 or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2013
From: KATZ, JASON D; JEWELL, JAMES P; SLOMAN, DAVID L; KNOWLES, SANDRA L; STANTON, MATTHEW G; NOUCTI, NJAMKOU
To: MERCK SHARP & DOHME CORP.
Reel/Frame 030319/0523 →